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ABSTRACT 
The objective of this study is to prepare nanogels were prepared via charged gellan gum. It was prepared by in situ cross linking 
reaction between two oppositely charged materials by green method without use of chemical cross linking agents. The prepared 
nanogels were characterized by dynamic light scattering, scanning electron microscopy, differential scanning calorimetry and X- 
Ray diffractometry. The prepared formulation had average particle size of 226 nm with polydispersity index of 0.3. The doxorubicin 
loaded nanogel demonstrated sustained release for 20 h. The prepared nanogels were hemocompatible and cyctocompatible as 
revealed by hemocompatibility and MTT assay respectively. All results confirmed that these nanogels can be used for cancer 
treatment. 
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INTRODUCTION  
Cancer is a prospective incurable illness, characterize by 
unwanted proliferation and spread of normal cells 
1
. In 
spite of the increase of many anticancer drugs, there are 
still challenges in employing them in cancer therapy 
because of their poor bioavailability, water insolubility, 
high toxicity and nonspecific targeting which result in 
damaging the healthy cells. Doxorubicin (DOX) is one 
of the most effective anticancer drugs, with a wide scope 
of activity in human cancers, including acute 
lymphoblastic leukemia, breast carcinoma, ovarian 
carcinoma, and hepatocellular carcinoma 
2
. However, its 
clinical application is limited by its harmful side effects, 
the most significant of which is its cardio toxicity that 
can lead to cardio myopathy and congestive heart 
failure
3
. 
Nanogels are defined as clear, thermodynamically 
stable, isotropic mixture of oil, water and surfactant 
frequently in combination with a co surfactant 
4
. The 
concept of nanogels was first introduced by Hoar and 
Schulman in 1942 and the term nanogels was first 
coined by Schulman and coworkers in 1959 to describe 
the clear fluid systems obtained by titration to the point 
of clarity of an ordinary milky gel (macro emulsion) by 
the addition of a medium chain alcohol such as pentanol 
and hexanol. The droplet size (100-600 nm) was much 
smaller than that of milky white ordinary emulsion; 
hence their transparent appearance and the adoption of 
the term nanogels (Schulman et al., 1959) 
5, 6
. 
Thus it decided, in this study that formulation of 
doxorubicin containing nanogel and evaluated for anti-
cancer activity.  
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MATERIALS AND METHODS  
Materials  
Chitosan (degree of deacetylation ~ 79%, Low mol wt 
,Viscosity 200-800 cP, 1 wt. % in 1% acetic acid) from 
Sigma Aldrich, India, Gellan gum (Low acyl content, 
mol. wt > 70,000 Daltons) obtained as gift sample from 
Burzin and Leons, CP Kelco division of the Monsanto 
Company, USA. Doxorubicin (95% purity, Product no. 
0000155108) purchased from Hi Media Lab. Pvt. Ltd, 
Mumbai, India.  
Method  
Preparation of chitosan- gellan gum nanogel  
Chitosan 0.85% w/v solution was prepared in acetic acid 
and 0.04% w/v gellan gum solution was prepared in 
distilled water. Both the solutions were filtrated by 
vaccum filter using 0.22 μm filter paper. Chitosan solu-
tion added slowly to gellan gum under agitation at room 
temperature for 3h. The pH of the resultant solution was 
about 4.3 and was adjusted to pH 5.4. The mixture was 
heated at 80˚C for 20 min to produce homogeneously 
dispersed nanogel, and then the nanogels were separated 
by centrifugation at 45,000 rpm for 35 minutes 
(Beckman Coulter, ultracentrifuge) 
7
.  
Preparation of Doxorubicin loaded chitosan- gellan 
gum nanogel  
Doxorubicin was loaded into the nanogel along with 
chitosan solution and the same procedure was followed 
as described for chitosan – gellan gum nanogel. The 
doxorubicin loaded nanogels were separated by 
centrifugation at 45,000 rpm for 35 minutes (Beckman 
Coulter ultracentrifuge). Deposited particles were re 
dispersed in distilled water containing 5% mannitol as a 
cryoprotectant. The resultant dispersion was subjected to 
lyophilisation at -75°C and vacuum was maintained at 
76 m Torr (Vertis Lyophilizer) 
8
. 
Characterization of nanogel  
The average particle size and polydispersity index was 
determined by photon correlation spectroscopy and Zeta 
potential of system was measured using Zeta sizer, 
(Nano ZS 90, Malvern Instrument., UK). The surface 
morphology of nanogel was examined by scanning 
electron® microscopy (JSM 6390, Japan). To 
demonstrate physical state of doxorubicin within 
nanogels, differential scanning calorimetry (DSC, 
Mettler-Toledo, Zurich, Switzerland), and X-ray 
diffractometry (XRD, Brucker Axs, D8 Advance; 
Germany) analysis were performed 
9
. 
Entrapment Efficiency, Loading Efficiency and In 
Vitro Drug Release Studies of Doxorubicin Loaded 
Nanogel  
Doxorubicin entrapment in chitosan-gellan gum nanogel 
formulation was determined by triturating lyophilized 
powder with DMSO and methanol in mortar pestle and 
diluted up to 10 ml in volumetric flask. The resulting 
solution was centrifuged at 30,000 rpm for 20 min and 
the supernatant was collected and analyzed 
spectrophotometrically (UV 1700, Shimadzu, Japan) at 
423 nm. Drug content was estimated using equation (y = 
0.08x - 0.010) generated as result of plot of 
concentration vs absorbance that obeys Beer’s and 
Lambert’s law in concentration range 2 to 12μg/mL. 
Loading efficiency was calculated in relation to yield of 
nanogel obtained after lyophilisation (equation- 1).  
                    
                                    
                                      
     
Entrapment efficiency was calculated on the basis of 
total amount of doxorubicin in nanogel to total amount 
of doxorubicin used during drug loading.10 (equation 2)  
                        
                                   
                        
     
In vitro doxorubicin release from nanogel formulation 
was carried out by using Franz type diffusion cell of 25 
ml capacity. Dialysis membrane (Himedia, Avg mol. 
weight cut off range 12000 – 14000 kDa) was used as 
diffusion membrane. Dialysis membrane was soaked in 
phosphate buffer pH 7.4 for 24 h prior to experiment. 
Diffusion cell was filled with buffer solution and 
dialysis membrane was mounted on cell. The 
temperature was maintained at 37
o
C ± 0.5
o
C. After a 
pre-incubation time of 20 minutes, the lyophilized 
nanogel was placed in the donor chamber. Samples were 
periodically withdrawn from the receptor compartment 
and replaced with the same amount of fresh buffer 
solution, and assayed by a UV spectrophotometer at 423 
nm 
10
.  
To evaluate the mechanism of drug release from the 
nanogel, data for the drug release was plotted in Kors-
meyer-Peppas equation. The release exponent n and K 
value was calculated through the slope of the straight 
line. 
3 
  
  
   n 
Hemolysis Assay  
The blood compatibility of the chitosan –gellan gum 
nanogel by hemolysis assay using human blood obtained 
from blood bank. In different concentrations of nanogel 
(0.2, 0.4, 0.6, 0.8,1 mg/ml), 0.1 ml of anti coagulated 
fresh human blood was added. Positive and negative 
control selected for this study were PBS (0% hemolysis) 
and 0.1% of Na2Co3 (100% Hemolysis). After incuba-
tion at 37 for 90 min sample were centrifuge at 4500 
rpm for 5 min. Absorbance of supernant was analyzed 
spectrophotometrically against PBS at 545 nm 
11
. 
The percentage of haemolysis was calculated by the fol-
lowing equation 4. 
            
                                     
                       
     
Cell culture protocol  
Astrocytoma-glioblastoma cell line (U373MG) was used 
for this study .The cells were seeded into 96-well plates 
at a density of 1.0 × 104 cells per well and grown in 
Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 10% fetal bovine serum (FBS), 100 
μg/mL penicillin, 200 μg/mL streptomycin, 2 mM L-
glutamine; and culture was maintained in a humidified 
atmosphere with 5% CO2.The cells were divided into 
two treatment groups, including: (a) doxorubicin sus-
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pension and (b) freeze dried doxorubicin loaded nanogel 
and % growth inhibition was determined by MTT assay 
based on mitochondrial reduction of yellow MTT tet-
razolium dye to highly colored blue formazan product. 
The plates were incubated for 48h at 37 ± 0.5°C in 
RPMI/DMEM/MEM with 10% FBS medium. Then the 
above media was replaced with 90μL of fresh serum 
free media and 10 μL of MTT reagent (5mg/mL) and 
plates were incubated at 37 ± 0.5°C for 4 h, there after 
the above media was replaced with 200μL of DMSO 
and incubated at 37±0.5°C for 10 min. Further studies 
were carried in accordance with our previous protocol 
12
. 
RESULTS AND DISCUSSION  
Preparation and characterization of doxorubicin 
loaded chitosan- gellan gum nanogel  
Doxorubicin loaded chitosan- gellan gum nanogel was 
formed immediately as result of cross-linking between 
positively charged chitosan and negatively charged gel-
lan gum by co- acervation reaction due to electrostatic 
attraction between two opposite charged polymers. 
However, the networks thus obtained by in situ cross- 
linking are reversible and unable to retain integrity of 
nanogel system. Heating at 80ºC for 20 min leads to 
formation of nanogel; these nanogels have good stability 
and do not require any stabilizer. Doxorubicin loaded 
nanogel was obtained by addition of doxorubicin to chi-
tosan solution prior to cross-linking with gellan gum.  
Characterization of Nanogel  
The average particle size for chitosan- gellan gum nano-
gel was found to be 201 nm and 226 nm for doxorubicin 
loaded nanogel with polydispersity index value of 0.31 
and 0.39 respectively, demonstrating uniform distri-
bution of nanogel population. Such nano range size 
distribution crucial for passive tumor targeting due to 
enhanced permeation and retention effect as majority of 
solid tumors exhibit a vascular pore cut-offs between 
380 and 780 nm.
13
 From SEM image of nanogel it is 
clear that the freeze dried nanogel have smooth surface 
with porous nature. Zeta potential of freeze dried 
doxorubicin loaded nanogel was found to be 5.52. The 
Zeta potential represents the electrical charge to the 
nanogel surface suggest that chitosan molecules are 
enriched on the particle surface. During thermal analysis 
doxorubicin showed strong endothermic peak at a 
temperature around 180 ºC, due to its crystalline nature 
(Figure 2A) but nanogel formulation displayed absence 
of peak in this region (Figure 2B). Also in X-ray 
diffractometry pattern numerous crystalline peaks were 
observed in the 2θ range of 15- 30º demonstrate 
crystalline nature of doxorubicin (Figure 3A) where as 
there were decrease in peak intensity in nanogel 
formulation confirms the amorphous state of 
doxorubicin in nanogel (Figure 3B). 
  
 
Figure 1: SEM image of freeze dried Doxorubicin loaded nanogel 
 
Figure 2: DSC thermaogram of Doxorubicin (A) and nanogel (B) 
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Figure 3: X- Ray Diffractogram of Doxorubicin (A) and nanogel (B) 
 
Entrapment efficiency, Loading efficiency and drug 
release studies  
The loading and entrapment efficiency of doxorubicin 
loaded nanogel system was found to be 5.66 ± 0.78% 
and 96.60± 1.28% respectively. The higher entrapment 
of doxorubicin in nanogel structure is attributed to in situ 
cross linking between two polymers and addition of 
doxorubicin prior to completion of interaction. To estab-
lish the suitability of chitosan – gellan gum nanogel as 
delivery system for doxorubicin, the in vitro release was 
studied. The release profile of doxorubicin -loaded 
nanogel was studied using dialysis membrane. Sustained 
release of doxorubicin from nanogel was observed 
(Figure 4a). The corresponding plot of Korsmeyer - 
Peppa’s equation (Figure 4b) indicated a good linearity 
of regression coefficient (R2) 0.913. The release 
exponent (n) of Korsmeyer-Peppa’s equation was found 
to be 0.91 and K value 0.869. The n value was greater 
than 0.5 and less than 1 indicating anomalous (non-
fickian) transport mechanism suggesting doxorubicin 
release due to diffusion through swell chitosan- gellan 
gum matrix. 
 
 
Figure 4: Doxorubicin release profile (A) and release mechanism (B) 
 
Haemolysis Assay  
Haemocompatibility of the nanogels was essential as 
nanogels are designed for drug delivery purpose that 
interacts with a large fraction of blood component in the 
blood before distribution to individual tissue. For drug 
delivery purpose nanogels must show minimum 
interaction with components in the blood stream and 
should possess long-term stability. On analysis of hae-
molytic potential of five different concentrations of 
nanogels it was observed that increase in nanogel con-
centration leads to increase in hemolytic ratio (Figure 5). 
It is about to 2.5% i.e. below 5 %, the critical safe 
hemolytic ratio for bio-materials, indicated that these 
chitosan-gellan gum nanogel samples are compatible 
with blood components.  
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Figure 5: Hemocompatibility of nanogels 
 
Cytotoxicity Studies  
Cytotoxicity assay of doxorubicin loaded nanogel was 
performed and compared with standard (doxorubicin) by 
cell viability testing. Figure 6 shows plot of % inhibition 
of astrocytoma-glioblastoma cell line (U373MG) 
incubated with the doxorubicin loaded nanogel vs 
doxorubicin. The IC50 values were found out to be 9.8 
and 13.6 ng/ml for doxorubicin loaded nanogel and 
doxorubicin suspension respectively. Thus, doxorubicin 
loaded nanogel showed lower cellular viability 
demonstrating increased cytotoxicity of formulation 
towards cells. 
 
 
Figure 6: In vitro cytotoxicity assay 
 
CONCLUSION  
Doxorubicin loaded chitosan- gellan gum nanogels were 
prepared by in situ cross-linking between two oppositely 
charged polymers. The prepared nanogels subjected 
good stability devoid of use of external chemical cross-
linkers. Prepared nanogels were characterized for 
particle size, zeta potential, and surface morphology. 
The result of particle size analysis reveals there suitabil-
ity for effective tumor targeting. The prepared nanogel 
showed porous nature due to lyophilisation with positive 
zeta potential confirming dominance of chitosan on 
surface. The doxorubicin loaded nanogel showed good 
entrapment efficiency and sustained drug release. In 
vitro cytotoxicity and hemocompatability assay proved 
the nontoxic and hemocompatible nature of the nano-
gels. These results indicated that chitosan- gellan gum 
nanogel could be suitable carrier for doxorubicin in 
cancer treatment. 
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